The Engine for Functional Immune Cell Profiling and Receptor Discovery

We analyze, understand, and manipulate massive numbers of cells on the single cell level to develop more effective treatments for human diseases.

Powered by Our Proprietary Platform

Our proprietary ultra-high throughput single cell platform enables us to functionally profile millions of immune cells on the single cell level at the same time, pulling out rare and difficult-to-find targets that are like the needles in a haystack. This allows us to create immunotherapies that are more targeted and more effective. We are using this unique platform to first develop cell therapies for solid tumors.

Centered around people

We believe that people are the key that drives scientific and organizational successes. We are dedicated to building an environment where everyone thrives. We have a culture of collaboration, ownership, and authenticity. We are proud to have built an interdisciplinary team that embodies this culture.

Careers

We love working with great people and solving critical problems. Come join us.

Current openings

Senior Scientist in TCR Sequencing

San Francisco, CA

Full Time

Senior Scientist in Bioinformatics (Bioinformatician)

San Francisco, CA

Full Time

Principal Scientist in Immunology

San Francisco, CA

Full Time

VP of Research and Development

San Francisco, CA

Full Time

Leadership and Scientific Advisors

Li Sun, PhD

CEO & Founder

Former VC at Foundation Capital and Bessemer Venture Partners, PhD in Applied Physics from Harvard University

Kaveh Milaninia, PhD

CTO & Head of Platform

Serial entrepreneur in life science tools, PhD in Materials Science from Massachusetts Institute of Technology

David Weitz, PhD

Scientific Advisor

Expert in single cell platforms, Professor of Physics and Applied Physics at Harvard University

Joseph Fraietta, PhD

Scientific Advisor

T cell therapy expert, Director of the Solid Tumor Immunotherapy Lab at University of Pennsylvania

Benjamin Greenbaum, PhD

Scientific Advisor

Expert in neoantigen prediction, Computational Oncologist at Memorial Sloan Kettering Cancer Center

Niroshana Anandasabapathy, MD/PhD

Scientific Advisor

Melanoma expert, Associate Professor of Dermatology in Microbiology and Immunology at Weill Cornell Medicine

Jonathan Esensten, MD/PhD

Scientific Advisor

Expert in cell therapy development and manufacturing, Medical Director of the GMP facility at University of California, San Francisco.

Paul Thomas, PhD

Scientific Advisor

T cell expert, Faculty in the Immunology Department at St. Jude Hospital

Work With Us to Cure Cancer

Partner With Us Join Us